Literature DB >> 18483178

Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain.

John R Hawse1, Malayannan Subramaniam, David G Monroe, Amanda H Hemmingsen, James N Ingle, Sundeep Khosla, Merry Jo Oursler, Thomas C Spelsberg.   

Abstract

The estrogen receptors (ER) alpha and beta are important ligand-mediated transcription factors known to play significant biological roles in numerous tissues including bone. Despite the high homology shared by these receptors, recent studies have suggested that their function is largely unique. Although these receptors have been studied in detail for more than a decade, little data exist concerning the mechanisms by which these two proteins regulate distinct sets of genes. Using the TGFbeta-inducible early gene-1 (TIEG) as a model, we demonstrate that TIEG is rapidly induced in response to estrogen in osteoblasts by ERbeta, but not ERalpha. We have identified the regulatory elements utilized by ERbeta and have demonstrated that ERbeta recruits steroid receptor coactivator (SRC)1 and SRC2 to this regulatory region. Additionally, deletion of the ERbeta-activation function 1 (AF1) domain drastically decreases the estrogen induction of TIEG. Through the use of chimeric receptors, we have demonstrated that the AF1 domain of ERbeta is responsible for recruiting SRC1 and SRC2 and inducing the expression of TIEG in osteoblasts. Finally, SRC1, but not SRC2, is essential for TIEG induction by ERbeta. Overall, these data demonstrate that the estrogen induction of TIEG is ERbeta specific and that the AF1 domain of ERbeta confers this specificity. Finally, a novel and important role for ERbeta's AF1 is implicated in the recruitment of specific coactivators, suggesting that the AF1 may play a significant role in conferring the differences in regulation of gene expression by these two receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483178      PMCID: PMC2453604          DOI: 10.1210/me.2007-0253

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  71 in total

1.  TGFbeta inducible early gene-1 knockout mice display defects in bone strength and microarchitecture.

Authors:  Sabine F Bensamoun; John R Hawse; Malayannan Subramaniam; Brice Ilharreborde; Armelle Bassillais; Claude L Benhamou; Daniel G Fraser; Merry J Oursler; Peter C Amadio; Kai-Nan An; Thomas C Spelsberg
Journal:  Bone       Date:  2006-07-28       Impact factor: 4.398

2.  Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements.

Authors:  B Saville; M Wormke; F Wang; T Nguyen; E Enmark; G Kuiper; J A Gustafsson; S Safe
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

3.  p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.

Authors:  Y Kobayashi; T Kitamoto; Y Masuhiro; M Watanabe; T Kase; D Metzger; J Yanagisawa; S Kato
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

4.  Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.

Authors:  J An; R C Ribeiro; P Webb; J A Gustafsson; P J Kushner; J D Baxter; D C Leitman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Functional differences between the amino-terminal domains of estrogen receptors alpha and beta.

Authors:  F Delaunay; K Pettersson; M Tujague; J A Gustafsson
Journal:  Mol Pharmacol       Date:  2000-09       Impact factor: 4.436

6.  Transcriptional activation of deoxyribonucleic acid polymerase alpha gene expression in MCF-7 cells by 17 beta-estradiol.

Authors:  I Samudio; C Vyhlidal; F Wang; M Stoner; I Chen; M Kladde; R Barhoumi; R Burghardt; S Safe
Journal:  Endocrinology       Date:  2001-03       Impact factor: 4.736

Review 7.  Role of estrogen receptor beta in estrogen action.

Authors:  K Pettersson; J A Gustafsson
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

8.  Overexpression of a nuclear protein, TIEG, mimics transforming growth factor-beta action in human osteoblast cells.

Authors:  T E Hefferan; G G Reinholz; D J Rickard; S A Johnsen; K M Waters; M Subramaniam; T C Spelsberg
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

9.  Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.

Authors:  Frank J Secreto; David G Monroe; Shamit Dutta; James N Ingle; Thomas C Spelsberg
Journal:  J Cell Biochem       Date:  2007-08-01       Impact factor: 4.429

10.  TIEG-null mice display an osteopenic gender-specific phenotype.

Authors:  J R Hawse; U T Iwaniec; S F Bensamoun; D G Monroe; K D Peters; B Ilharreborde; N M Rajamannan; M J Oursler; R T Turner; T C Spelsberg; M Subramaniam
Journal:  Bone       Date:  2008-03-04       Impact factor: 4.398

View more
  23 in total

1.  Kruppel-like factor KLF10 is a link between the circadian clock and metabolism in liver.

Authors:  Fabienne Guillaumond; Aline Gréchez-Cassiau; Malayannan Subramaniam; Sophie Brangolo; Brigitta Peteri-Brünback; Bart Staels; Catherine Fiévet; Thomas C Spelsberg; Franck Delaunay; Michèle Teboul
Journal:  Mol Cell Biol       Date:  2010-04-12       Impact factor: 4.272

Review 2.  Estrogen and bones after menopause: a reappraisal of data and future perspectives.

Authors:  Panagiotis Anagnostis; Julia K Bosdou; Konstantina Vaitsi; Dimitrios G Goulis; Irene Lambrinoudaki
Journal:  Hormones (Athens)       Date:  2020-06-09       Impact factor: 2.885

3.  TIEG and estrogen modulate SOST expression in the murine skeleton.

Authors:  Malayannan Subramaniam; Kevin S Pitel; Elizabeth S Bruinsma; David G Monroe; John R Hawse
Journal:  J Cell Physiol       Date:  2017-11-24       Impact factor: 6.384

Review 4.  Functional role of KLF10 in multiple disease processes.

Authors:  Malayannan Subramaniam; John R Hawse; Nalini M Rajamannan; James N Ingle; Thomas C Spelsberg
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

5.  TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts.

Authors:  M Subramaniam; J R Hawse; E S Bruinsma; S B Grygo; M Cicek; M J Oursler; T C Spelsberg
Journal:  Biochem Biophys Res Commun       Date:  2010-01-06       Impact factor: 3.575

6.  TGFβ inducible early gene-1 plays an important role in mediating estrogen signaling in the skeleton.

Authors:  John R Hawse; Kevin S Pitel; Muzaffer Cicek; Kenneth A Philbrick; Anne Gingery; Kenneth D Peters; Farhan A Syed; James N Ingle; Vera J Suman; Urszula T Iwaniec; Russell T Turner; Thomas C Spelsberg; Malayannan Subramaniam
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

7.  Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.

Authors:  Philip Jonsson; Anne Katchy; Cecilia Williams
Journal:  Endocr Relat Cancer       Date:  2014-01-30       Impact factor: 5.678

8.  TIEG1 enhances Osterix expression and mediates its induction by TGFβ and BMP2 in osteoblasts.

Authors:  Malayannan Subramaniam; Kevin S Pitel; Sarah G Withers; Hicham Drissi; John R Hawse
Journal:  Biochem Biophys Res Commun       Date:  2016-01-20       Impact factor: 3.575

9.  Sclerostin antibody treatment rescues the osteopenic bone phenotype of TGFβ inducible early gene-1 knockout female mice.

Authors:  Anne Gingery; Malayannan Subramaniam; Kevin S Pitel; Xiaodong Li; Hua Z Ke; Russell T Turner; Urszula T Iwaniec; John R Hawse
Journal:  J Cell Physiol       Date:  2020-01-24       Impact factor: 6.384

Review 10.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.